146 related articles for article (PubMed ID: 11042666)
1. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
[TBL] [Abstract][Full Text] [Related]
2. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
[TBL] [Abstract][Full Text] [Related]
4. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.
Ishimura M; Ohga S; Nomura A; Toubo T; Morihana E; Saito Y; Nishio H; Ide M; Takada H; Hara T
Am J Hematol; 2005 Nov; 80(3):207-12. PubMed ID: 16247742
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of natural killer (NK) cell leukemia following a long-standing chronic active Epstein-Barr virus (CAEBV) infection with allogeneic bone marrow transplantation.
Ebihara Y; Manabe A; Tanaka R; Yoshimasu T; Ishikawa K; Iseki T; Hayakawa J; Maeda M; Asano S; Tsuji K
Bone Marrow Transplant; 2003 Jun; 31(12):1169-71. PubMed ID: 12796798
[TBL] [Abstract][Full Text] [Related]
6. Chronic active Epstein-Barr virus infection (CAEBV) successfully treated with allogeneic peripheral blood stem cell transplantation.
Taketani T; Kikuchi A; Inatomi J; Hanada R; Kawaguchi H; Ida K; Oh-Ishi T; Arai T; Kishimoto H; Yamamoto K
Bone Marrow Transplant; 2002 Mar; 29(6):531-3. PubMed ID: 11960276
[TBL] [Abstract][Full Text] [Related]
7. [CD34+ progenitor cell transplantation from HLA-mismatched donors to two patients with chronic active Epstein-Barr virus infection].
Yasui M; Okamura T; Sakata N; Inoue M; Yagi K; Yoshimoto T; Mabuchi O; Sano M; Kawa K
Rinsho Ketsueki; 2001 Nov; 42(11):1111-6. PubMed ID: 11808080
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation.
Takami A; Nakao S; Yachie A; Kasahara Y; Okumura H; Miura Y; Sugimori N; Zeng W; Wang H; Kotani T; Shiobara S; Matsuda T
Bone Marrow Transplant; 1998 Jun; 21(12):1279-82. PubMed ID: 9674865
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
[TBL] [Abstract][Full Text] [Related]
10. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease.
Lucas KG; Salzman D; Garcia A; Sun Q
Cancer; 2004 May; 100(9):1892-901. PubMed ID: 15112270
[TBL] [Abstract][Full Text] [Related]
11. [Allogeneic peripheral blood stem cell transplantation for a hepatitis B virus carrier with Epstein-Barr virus associated with hemophagocytic syndrome].
Sakai R; Maruta A; Yamazaki E; Kamijo A; Taguchi J; Hyo R; Tanaka M; Fujimaki K; Nagao T; Yoshiba M; Ishigatsubo Y
Rinsho Ketsueki; 2004 May; 45(5):397-401. PubMed ID: 15199750
[TBL] [Abstract][Full Text] [Related]
12. Complete resolution of severe chronic active Epstein-Barr virus infection by cultured, activated donor T lymphocyte infusion after nonmyeloablative stem cells allografting.
Yoshiba F; Hagihara M; Tazume K; Ogawa Y; Kishi K; Higuchi A; Kato S; Hotta T
Bone Marrow Transplant; 2003 Jul; 32(1):107-10. PubMed ID: 12815486
[TBL] [Abstract][Full Text] [Related]
13. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
14. Two cases of chronic active Epstein-Barr virus infection in which EBV-specific cytotoxic T lymphocyte was induced after allogeneic bone marrow transplantation.
Miyamura T; Chayama K; Wada T; Yamaguchi K; Yamashita N; Ishida T; Washio K; Morishita N; Manki A; Oda M; Morishima T
Pediatr Transplant; 2008 Aug; 12(5):588-92. PubMed ID: 18266798
[TBL] [Abstract][Full Text] [Related]
15. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S
Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
17. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
20. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
